Lifeward Ltd. (LFWD)
NASDAQ: LFWD · Real-Time Price · USD
1.500
+0.010 (0.67%)
At close: Dec 20, 2024, 4:00 PM
1.590
+0.090 (6.00%)
After-hours: Dec 20, 2024, 7:28 PM EST
Lifeward Market Cap
Lifeward has a market cap or net worth of $13.21 million as of December 20, 2024. Its market cap has decreased by -67.62% in one year.
Market Cap
13.21M
Enterprise Value
3.54M
1-Year Change
-67.62%
Ranking
Category
Stock Price
$1.50
Market Cap Chart
Since September 12, 2014, Lifeward's market cap has decreased from $294.80M to $13.21M, a decrease of -95.52%. That is a compound annual growth rate of -26.07%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 20, 2024 | 13.20M | -71.73% |
Dec 29, 2023 | 46.70M | -0.85% |
Dec 30, 2022 | 47.10M | -38.67% |
Dec 31, 2021 | 76.80M | 203.56% |
Dec 31, 2020 | 25.30M | 60.13% |
Dec 31, 2019 | 15.80M | 154.84% |
Dec 31, 2018 | 6.20M | -74.49% |
Dec 29, 2017 | 24.30M | -46.83% |
Dec 30, 2016 | 45.70M | -73.63% |
Dec 31, 2015 | 173.30M | -20.29% |
Dec 31, 2014 | 217.40M | -26.26% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Acurx Pharmaceuticals | 13.94M |
Innovative Eyewear | 13.92M |
ImmunoPrecise Antibodies | 13.42M |
Impact BioMedical | 13.34M |
Cingulate | 13.17M |
Kazia Therapeutics | 13.15M |
Brainstorm Cell Therapeutics | 13.00M |
Eterna Therapeutics | 12.85M |